Ralimetinib (LY2228820)

Ralimetinib (LY2228820)

  • $970.00
    Unit price per 
Shipping calculated at checkout.


Ralimetinib (LY2228820) is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.

We Also Recommend

×
Welcome Newcomer